Miller K - Search Results

1

Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer.

DesJardin JA, Falagas ME, Ruthazer R, Griffith J, Wawrose D, Schenkein D, Miller K, Snydman DR. DesJardin JA, et al. Among authors: miller k. Ann Intern Med. 1999 Nov 2;131(9):641-7. doi: 10.7326/0003-4819-131-9-199911020-00002. Ann Intern Med. 1999. PMID: 10577325

2

Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.

Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J, Snydman DR. Koc Y, et al. Among authors: miller kb. Biol Blood Marrow Transplant. 2000;6(1):44-9. doi: 10.1016/s1083-8791(00)70051-6. Biol Blood Marrow Transplant. 2000. PMID: 10707998 Free article. Clinical Trial.

3

Vancomycin-resistant enterococcal infections in bone marrow transplant recipients.

Koc Y, Snydman DR, Schenkein DS, Miller KB. Koc Y, et al. Among authors: miller kb. Bone Marrow Transplant. 1998 Jul;22(2):207-9. doi: 10.1038/sj.bmt.1701303. Bone Marrow Transplant. 1998. PMID: 9707033

4

Hematology.

Miller KB, Schenkein DP. Miller KB, et al. JAMA. 1993 Jul 14;270(2):216-7. JAMA. 1993. PMID: 8315737 No abstract available.

5

Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.

Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Poutsiaka DD, et al. Among authors: miller kb. Bone Marrow Transplant. 2007 Jul;40(1):63-70. doi: 10.1038/sj.bmt.1705690. Epub 2007 Apr 30. Bone Marrow Transplant. 2007. PMID: 17468772

6

A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT.

Klein A, Miller KB, Sprague K, DesJardin JA, Snydman DR. Klein A, et al. Among authors: miller kb. Bone Marrow Transplant. 2011 Feb;46(2):294-9. doi: 10.1038/bmt.2010.99. Epub 2010 Apr 26. Bone Marrow Transplant. 2011. PMID: 20421867 Clinical Trial.

7

Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.

Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C, Berkman E, Schenkein D. Kanteti R, et al. Among authors: miller k. Bone Marrow Transplant. 1999 Sep;24(5):473-81. doi: 10.1038/sj.bmt.1701941. Bone Marrow Transplant. 1999. PMID: 10482930 Clinical Trial.

8

An assessment of the safety and tolerability of immune globulin intravenous (human) Sandoglobulin prepared in sterile water or 5% dextrose at various concentrations.

Miller KB, Schenkein DP, Fogaren T. Miller KB, et al. Semin Hematol. 1992 Jul;29(3 Suppl 2):109-11. Semin Hematol. 1992. PMID: 1509290 No abstract available.

9

Safety and tolerability of an intravenous immune globulin at various concentrations in 5% dextrose injection or sterile water for injection.

Miller KB, Schenkein DP, Wasserman RL. Miller KB, et al. Clin Pharm. 1992 Jul;11(7):628-31. Clin Pharm. 1992. PMID: 1617914 No abstract available.

10

Accelerated bone formation causing profound hypocalcemia in acute leukemia.

Schenkein DP, O'Neill WC, Shapiro J, Miller KB. Schenkein DP, et al. Among authors: miller kb. Ann Intern Med. 1986 Sep;105(3):375-8. doi: 10.7326/0003-4819-105-3-375. Ann Intern Med. 1986. PMID: 3461737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,528 results

Search Page